Literature DB >> 25118641

Retroperitoneal unicentric Castleman's disease-a hyaline vascular challenge.

Archer Kilbourne Martin1, John A Stauffer.   

Abstract

Castleman's disease is a rare lymphoproliferative disorder. Multiple variants of the disease exist, with differentiation based on tissue pathology and number of masses within the body. We present the medical diagnostic and surgical treatment pathway of a retroperitoneal unicentric hyaline vascular variant complicated by close proximity to major vascular structures.

Entities:  

Mesh：

Year:  2014        PMID： 25118641     DOI： 10.1007/s11605-014-2622-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


  5 in total

Review 1.  The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

Authors:  Corey Casper
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

2.  Multidisciplinary approach to the treatment of cardiac AA amyloidosis and aortic stenosis due to Castleman's disease: a hybrid therapy with tocilizumab and aortic valve replacement.

Authors:  Kohsuke Shirakawa; Toru Egashira; Masaki Ieda; Shinji Kawaguchi; Kazuma Okamoto; Mikihiko Kudo; Kenji Yokoyama; Hikaru Tsuruta; Mitsushige Murata; Shuji Mikami; Atsushi Anzai; Kentaro Hayashida; Takashi Kohno; Yuichiro Maekawa; Motoaki Sano; Ryohei Yozu; Keiichi Fukuda
Journal:  Int J Cardiol       Date:  2014-03-16       Impact factor: 4.164

3.  Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres.

Authors:  Don Robinson; Matthew Reynolds; Corey Casper; Angela Dispenzieri; Jessica Vermeulen; Krista Payne; Judy Schramm; Kay Ristow; Marie-Pierre Desrosiers; Karen Yeomans; Dana Teltsch; Richard Swain; Thomas M Habermann; Philip Rotella; Helgi Van de Velde
Journal:  Br J Haematol       Date:  2014-01-06       Impact factor: 6.998

4.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Authors:  S J Brandt; D M Bodine; C E Dunbar; A W Nienhuis
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 5.  HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Authors:  David C Fajgenbaum; Frits van Rhee; Christopher S Nabel
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113
  5 in total
  1 in total

Review 1.  Laparoscopic treatment of abdominal unicentric castleman's disease: a case report and literature review.

Authors:  Umberto Bracale; Francesco Pacelli; Marco Milone; Umberto Marcello Bracale; Maurizio Sodo; Giovanni Merola; Teresa Troiani; Enrico Di Salvo
Journal:  BMC Surg       Date:  2017-04-12       Impact factor: 2.102
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.